文献速递胃肠外科围术期管理与 ERAS

儿童加速康复方案实施与效果:ENRICH-US阶梯楔形整群随机试验

Implementation and Effectiveness of an Enhanced Recovery Protocol for Children Undergoing Surgery: The ENRICH-US Stepped-Wedge Cluster-Randomized Trial.
PubMed 文献 · JAMA Surg · 2026-01-01

该研究为2型混合实施-效果阶梯楔形整群随机试验,纳入597例10-18岁择期胃肠手术患儿,评估基于共识的21项儿童加速康复方案(ERP)的实施与临床效果。结果显示研究阶段间术后住院时间(LOS)无显著差异,但接受至少13项ERP元素的患者LOS更短且并发症更少。

要点

  • 儿童胃肠手术ERP未显著缩短总体术后住院时间。
  • 患者层面接受≥13项ERP元素与LOS缩短1.14天及并发症减少相关。
  • 患者层面ERP依从性随研究阶段显著提高。

核心结论

  • 尽管采用多层面实施策略,儿童胃肠手术ERP未显著降低术后住院时间。
  • 考虑患者层面实施保真度后,ERP与显著更短的住院时间和更少并发症相关。

研究设计与样本

  • 前瞻性2型混合实施-效果、阶梯楔形、按进入实施阶段日期整群随机的试验。
  • 纳入18个美国站点、10至18岁择期胃肠手术患儿,研究周期2019年9月至2024年6月。
  • 共纳入597例患儿,中位年龄15岁(IQR 13-17),女性274例(45.9%),男性323例(54.1%)。
  • 433例(72.5%)患有炎症性肠病。

主要发现

  • 研究阶段间术后住院时间及次要结局(包括阿片类药物使用、规律饮食时间、并发症、再入院、患者报告健康相关生活质量)无显著差异,除外规律饮食时间更短和住院期间阿片类药物使用减少。
  • 接受至少13项ERP元素的患者中位LOS缩短1.14天(95%CI -2.01至-0.27),并发症更少(调整OR 0.48,95%CI 0.28-0.82)。
  • 患者层面ERP依从性随研究阶段提高(ERP元素数:11[10-13]、14[12-15]、14[13-15],P<.001)。
  • ERP整合入医嘱套餐和站点文化与保真度呈中度相关。

关键数值与推荐

  • ERP为21项元素组成的共识方案,基于5项主动实施框架(5AIFs),由结构化实施工具包支持。
  • 实施阶段以6个月间隔推进,每站点至少经历9个月对照期(常规护理),随后进入实施期和维持期(12-24个月)。
  • 实施促进策略包括为期1年的小组学习协作课程、工具库、ERP依从性反馈和实施报告卡。

临床怎么用

  • 在儿童择期胃肠手术中可推行共识ERP,但需关注患者层面实际接受的ERP元素数量。
  • 提高ERP依从性(尤其是达到至少13项元素)可能缩短住院时间并降低并发症。
  • 将ERP整合入医嘱套餐和站点文化可能有助于提升实施保真度。

局限性

  • 原文未报告局限性相关内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Despite evidence that enhanced recovery protocols (ERPs) improve outcomes in adults undergoing surgery, adoption for pediatric populations has lagged. OBJECTIVE: To assess the implementation and clinical effectiveness of a consensus-based ERP for pediatric patients undergoing elective gastrointestinal (GI) surgery. DESIGN, SETTING, AND PARTICIPANTS: A prospective type 2 hybrid implementation-effectiveness, stepped-wedge, cluster-randomized by entry date into implementation phase, trial of pediatrics patients, 10 to 18 years of age, undergoing elective GI surgery at 18 US sites from September 2019 to June 2024. INTERVENTIONS: Sites were randomized into 3 groups, each spending at least 9 months in a control phase, with usual care, followed by an implementation phase at 6-month intervals that included a 21-element ERP supported by a structured Implementation Toolkit, based on 5 Active Implementation Frameworks (5AIFs), and a sustainment phase (12-24 months). Implementation was facilitated by a 1-year, group-based Learning Collaborative curriculum, a repository of tools, ERP adherence feedback, and implementation report cards. MAIN OUTCOMES AND MEASURES: Site-level scores were created based on 5AIFs domains. ERP adherence was assessed by ERP elements delivered at patient and site level. The primary effectiveness outcome, postoperative length of stay (LOS), and secondary effectiveness outcomes (including opioid use, time to regular diet, complications, readmission, and patient-reported health-related quality of life [HRQOL]) were evaluated across study phases (baseline, implementation, and sustainability). Correlations between site-level implementation scores and fidelity were estimated. RESULTS: Of the 597 enrolled pediatric patients (median [IQR] age, 15 [13-17] years; 274 [45.9%] female; 323 [54.1%] male), 433 (72.5%) had inflammatory bowel disease. No significant differences were found by study phase in LOS or secondary outcomes, except shorter time to regular diet and decreased opioid use during hospitalization. Patients who received at least 13 ERP elements had shorter median LOS (-1.14 days [95% CI -2.01 to -0.27]) and fewer complications (adjusted odds ratio, 0.48 [95% CI, 0.28-0.82]). Patient-level adherence increased by study phase (number of ERPs: 11 [10-13], 14 [12-15], and 14 [13-15], [P < .001]). ERP integration into order sets and site culture were moderately correlated with fidelity. CONCLUSIONS AND RELEVANCE: This stepped-wedge cluster-randomized trial found that despite multifaceted implementation strategies, a pediatric GI surgery ERP did not significantly reduce LOS. However, when accounting for implementation fidelity at the patient level, it resulted in significantly lower LOS and complications. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04060303.

来源:JAMA Surg,查看原文。版权归原作者所有。

引用

  1. Raval MV, Tian Y, Schäfer W, et al. Implementation and Effectiveness of an Enhanced Recovery Protocol for Children Undergoing Surgery: The ENRICH-US Stepped-Wedge Cluster-Randomized Trial. JAMA Surg. 2026. PMID: 42126839. doi:10.1001/jamasurg.2026.1382

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。